How does high blood pressure cause cerebral ischemia

Hypertension — consequences in the end organ, the brain

  • 1.

    Broderick J, Brott T, Barsan W et al. (1993) Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med 22: 1438-1443

    Google Scholar

  • 2.

    Brown MJ, Palmer CR, Castaigne A et al. (2000) Morbidity and mortality in patients randomized in double-blind treatment with a long-acting calcium-channel blocker or diuretic in the international nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 356: 366-372

    Google Scholar

  • 3.

    Carlberg B, Asplund K, Hägg E (1993) The prognostic value of admission blood pressure in patients with acute stroke. Stroke 24: 1372-1375

    Google Scholar

  • 4.

    Dahlof B, Devereux RB, Kjeldsen SE, et al. and the LIFE Study Group (2002) Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 359: 995-1003

    Google Scholar

  • 5.

    Grau AJ, Weimar C, Buggle F et al. (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32: 2559-2566

    Google Scholar

  • 6.

    Gueyffler F, Bulpitt C, Boissel JP et al. for the INDANA Group (1999) Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. Lancet 353: 793-796

    Google Scholar

  • 7.

    Hansson L, Hedner T, Lund-Johansen P et al. for the NORDIL study group (2000) Randomized trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the nordic diltiazem (NORDIL) study. Lancet 356: 359-365

    Google Scholar

  • 8.

    Hansson L, Lindholm LH, Ekbom T et al. (1999) Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in old patients with hypertension-2 study. Lancet 354: 1751-1756

    Google Scholar

  • 9.

    Hansson L, Lindholm LH, Niskanen L et al. for the Captopril Prevention Project (CAPP) Study Group (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. Lancet 353: 611-616

    Google Scholar

  • 10.

    Hansson L, Zanchetti A, Carruthers SG, et al. for the HOT Study Group (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 351: 1755-1762

    Google Scholar

  • 11.

    Hypertension Detection And Follow-Up Program Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242: 2562-2571

    Google Scholar

  • 12.

    Hypertension-Stroke Cooperative Study Group (1974) Effect of antihypertensive treatment on stroke recurrence. JAMA 229: 409-418

    Google Scholar

  • 13.

    Jorgensen HS, Nakayama H, Christensen HR, Raaschou HO, Kampmann JP, Olsen TS (2002) Blood pressure in acute stroke. The Copenhagen stroke study. Cerebrovasc Dis 13: 204-209

    Google Scholar

  • 14.

    Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS (1994) Effect of blood pressure and diabetes on stroke in progression. Lancet 344: 156-159

    Google Scholar

  • 15.

    Leonardi-Bee J, Bath P, Phillips S, Sandercock P, IST Collaborative Group (2002) Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33: 1315-1320

    Google Scholar

  • 16.

    MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774

    Google Scholar

  • 17.

    Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. BMJ 291: 97-104

    Google Scholar

  • 18.

    PATS Collaborative Group (1995) Post-stroke antihypertensive treatment study. Chin Med J 108: 710-717

    Google Scholar

  • 19.

    Progress Collaborative Group (2001) Randomized trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358: 1033-1041

    Google Scholar

  • 20.

    Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C (1996) Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 313: 147

    Google Scholar

  • 21.

    Schellinger PD, Steiner T (1998) Emergency and intensive treatment after a stroke. Neurologist 69: 530-539

    Google Scholar

  • 22.

    Schrader J, Lüders S, Kulschewski A et al. on behalf of the ACCESS Study Group (2003) Evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34: in press

  • 23.

    SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 265: 3255-3264

    Google Scholar

  • 24.

    Staessen JA, Fagard R, Thijs L et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators (1997) Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350: 757-764

    Google Scholar

  • 25.

    Staessen JA, Gasowski J, Wang JG et al. (2000) Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355: 865-872

    Google Scholar

  • 26.

    Staessen JA, Thijs L, O'Brien ET et al. (2002) Ambulatory pulse pressure as predictor of outcome in older patients with hypertension. Am J Hypertens 15: 835-843

    Google Scholar

  • 27.

    Stratton IM, Adler AI, Neil HAW et al. on behalf of the UK Prospective Diabetes Study Group (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BJM 321: 405-412

    Google Scholar

  • 28.

    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967-1975

  • 29.

    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288: 2981-2997

    Google Scholar

  • 30.

    The INDANA Project Collaborators (1997) Effect of antihypertensive treatment in patients having already suffered from stroke. gathering the evidence. Stroke 28: 2557-2562

    Google Scholar

  • 31.

    UK-TIA Study Group (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatr 54: 1044-1054

    Google Scholar

  • 32.

    Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T (1994) Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 4: 204-210

    Google Scholar

  • 33.

    Wing LHW, Reid CM, Ryan P et al. for the Second Australian National Blood Pressure Study Group (2003) A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348: 583-592

    Google Scholar